SCHEMBL8666559

SCHEMBL8666559

CCCCN1CCC(COC(=O)c2cccc3c2C2=CCCOC2C=C3)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 8/20 0.49
HTR2C P28335 3/20 0.46
ADRA2C P18825 2/20 0.46
HTR1D P28221 2/20 0.46
ADRA1A P35348 2/20 0.46
HTR2B P41595 2/20 0.46
ADRA2B P18089 1/20 0.46
ADRA1B P35368 1/20 0.46
HTR3A P46098 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
LMNA P02545 1/20 0.45
ADRA2A P08913 1/20 0.45
THRB P10828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9280925 0.73 HTR4 (0.52) HTR4HTR2CADRA2CHTR1DADRA1A
SCHEMBL14905735 0.72 HTR4 (0.72) HTR4HTR2CADRA2CHTR1DADRA1A
SCHEMBL7348157 0.71 HTR4 (0.41) HTR4ADRA1AADRA2BADRA1BADRA2A
SCHEMBL7391969 0.66 HTR4 (0.78) HTR4HTR2CADRA2CHTR1DADRA1A
SCHEMBL13439990 0.66 HTR4 (0.76) HTR4HTR2CADRA2CHTR1DADRA1A
SCHEMBL9341467 0.66 HTR4 (0.71) HTR4CYP1A2CYP2C9PMP22NPSR1
SCHEMBL13036127 0.65 HTR4 (0.80) HTR4CYP1A2CYP2D6CYP2C9PMP22
SCHEMBL7323178 0.65 HTR4 (0.72) HTR4HTR2CADRA2CHTR1DADRA1A
SCHEMBL9342314 0.65 HTR4 (0.58) HTR4CYP1A2CYP2C9PMP22NPSR1
SCHEMBL7328044 0.65 HTR4 (0.56) HTR4HTR2CADRA2CHTR1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5726187-A N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1998-03-10 US disclosed